17 postdoc-in-distributed-systems-and-controls Postdoctoral positions at Empa in Switzerland
Sort by
Refine Your Search
-
8 Mar 2025 Job Information Organisation/Company Empa Research Field Computer science » Programming Engineering » Materials engineering Engineering » Mechanical engineering Engineering » Other
-
. Empa is a research institution of the ETH Domain. In our Laboratory for Advanced Materials Processing in Thun, near Bern, we are currently looking for an outstanding candidate to conduct cutting-edge
-
20 Feb 2025 Job Information Organisation/Company Empa Research Field Chemistry » Other Physics » Optics Physics » Quantum mechanics Physics » Other Researcher Profile Recognised Researcher (R2
-
8 Mar 2025 Job Information Organisation/Company Empa Research Field Chemistry » Other Computer science » Informatics Computer science » Programming Computer science » Other Engineering » Electrical
-
15 Feb 2025 Job Information Organisation/Company Empa Research Field Chemistry » Other Engineering » Biomedical engineering Engineering » Materials engineering Researcher Profile Recognised
-
. Empa is a research institution of the ETH Domain. The Coating Technologies Group in Empa's Laboratory for Surface Science & Coating Technologies develops next-generation functional thin-films through
-
. Empa is a research institution of the ETH Domain. Dual-comb spectroscopy (DCS) is a rapidly evolving techniques opening up new fields of applications. Our aim is to leverage on quantum cascade laser (QCL
-
. Empa is a research institution of the ETH Domain. The Plasma & Coating Team at Empa, the Swiss Federal Laboratories for Materials Science and Technology (ETH Domain), aims to harness the power
-
. Empa is a research institution of the ETH Domain. Our Laboratory for Advanced Fibers in St. Gallen pursues application-driven research in the field of polymers and fibers. We work towards a new
-
. Empa is a research institution of the ETH Domain. The Nanomaterials in Health Lab enables particle-based solutions for diagnostics and therapeutics driven by clinical needs. We are active in